CMS chief criticizes Medicare drug payments for ‘perverse’ incentives
The Trump administration on Monday offered a new critique of the way Medicare pays for drugs administered by doctors, hinting at potential changes that could draw broad ire from drug makers, hospitals, and doctors.
